Literature DB >> 1494860

The influence of age on the pharmacokinetics of aditoprim in pigs after intravenous and oral administration.

J L Riond1, P Müller, M Wanner.   

Abstract

Some pharmacokinetic parameters of aditoprim were determined in 3- and 6-month-old pigs. After intravenous administration of 5 mg/kg body weight, the mean total body clearance of the older pigs was smaller than that of the younger pigs. This difference was not reflected in the elimination half-life. After oral administration of 5 mg/kg body weight, the mean absorption rate constant was smaller and the mean absorption half-life was longer in the older pigs. The age-related changes in the pharmacokinetics of aditoprim were not sufficiently pronounced to suggest the necessity of modifying the oral dosage regimen in pigs of this age range. The favourable pharmacokinetics of aditoprim in pigs (large apparent volume of distribution, long elimination half-life and high bioavailability) may permit introduction of this drug into swine practice, after safety and residue depletion studies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1494860     DOI: 10.1007/bf01839185

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  27 in total

Review 1.  Statistical analysis of pharmacokinetic data.

Authors:  J Powers
Journal:  J Vet Pharmacol Ther       Date:  1990-06       Impact factor: 1.786

2.  Half-life and renal excretion of trimethoprim in swine.

Authors:  P Nielsen; F Rasmussen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975-02

3.  Pharmacokinetics of aditoprim, a dihydrofolate reductase inhibitor, in sheep.

Authors:  K Haenni; J C Jordan; B Ludwig; W F Rehm
Journal:  J Vet Pharmacol Ther       Date:  1987-06       Impact factor: 1.786

4.  [Enteral absorption of drugs in rats of various ages. II. Absorption of foreign matter in vivo].

Authors:  H Hoffmann
Journal:  Acta Biol Med Ger       Date:  1971

5.  [Critical remarks on trimethoprim/sulfonamide combinations in veterinary medicine].

Authors:  W Löscher
Journal:  Dtsch Tierarztl Wochenschr       Date:  1984-04-09

6.  Pharmacokinetics: statistical moment calculations.

Authors:  A Gouyette
Journal:  Arzneimittelforschung       Date:  1983

7.  Enteral absorption and bioavailability in children in relation to age.

Authors:  G Heimann
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

8.  Some pharmacokinetic data of aditoprim and trimethoprim in healthy and tick-borne fever infected dwarf goats.

Authors:  N W Knoppert; S M Nijmeijer; C T van Duin; C Korstanje; H van Gogh; A S van Miert
Journal:  J Vet Pharmacol Ther       Date:  1988-06       Impact factor: 1.786

9.  Pharmacokinetics of gentamicin in the calf: developmental changes.

Authors:  C R Clarke; C R Short; R C Hsu; J D Baggot
Journal:  Am J Vet Res       Date:  1985-12       Impact factor: 1.156

10.  [Peculiarities of drug therapy in childhood].

Authors:  D Reinhardt; G Kusenbach
Journal:  Monatsschr Kinderheilkd       Date:  1986-11       Impact factor: 0.323

View more
  3 in total

1.  The antibacterial activities of aditoprim and its efficacy in the treatment of swine streptococcosis.

Authors:  Guyue Cheng; Yamei Xu; Xudong Zhu; Shuyu Xie; Liye Wang; Lingli Huang; Haihong Hao; Zhenli Liu; Yuanhu Pan; Dongmei Chen; Yulian Wang; Zonghui Yuan
Journal:  Sci Rep       Date:  2017-02-01       Impact factor: 4.379

2.  Preparation of Aditoprim Injection against Streptococcus suis in Pigs and a Dose Regimen Based on Pharmacokinetic-Pharmacodynamic Modeling.

Authors:  Wei Qu; Mengxiao Dong; Yuanhu Pan; Shuyu Xie; Zonghui Yuan; Lingli Huang
Journal:  Pharmaceutics       Date:  2022-03-28       Impact factor: 6.525

3.  Metabolism and Disposition of Aditoprim in Swine, Broilers, Carp and Rats.

Authors:  Liye Wang; Lingli Huang; Yuanhu Pan; Kamil Kuča; Blanka Klímová; Qinghua Wu; Shuyu Xie; Ijaz Ahmad; Dongmei Chen; Yanfei Tao; Dan Wan; Zhenli Liu; Zonghui Yuan
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.